Role of 5-HT1A-AR overexpression in affective disorders
Role of 5-HT1A-AR overexpression in affective disorders
批准号:
7119041
负责人:
Miles Berger
金额:
$3.01万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-09-01 至 2008-08-31
关键词:
REM sleepautoradiographybehavior testbehavioral /social science research tagbehavioral geneticscircadian rhythmsdisease /disorder modeldorsal raphe nucleuselectroencephalographyelectrophysiologyfrontal lobe /cortexgene expressiongenetically modified animalshippocampusimmunocytochemistrylaboratory mousemajor depressionmicrodialysisneural transmissionpredoctoral investigatorpsychopathologyserotoninserotonin inhibitorserotonin receptor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Major depression is a common mental illness thought to arise in part from decreased serotonin (5-HT) neurotransmission. Recent evidence suggests that this decrease may arise from increased expression of inhibitory 5-HT1A autoreceptors (5-HT1A-AR) on 5-HT neurons. To model this aspect of the pathophysiology of depression, I have created transgenic mice designed to overexpress 5-HT1A-AR; I hypothesize that these mice will have decreased 5-HT transmission and depressive-like behavior. Aim 1: Validate 5-HT1A-AR overexpression in transgenic mice by quantitative autoradiography and immunocytochemistry. Aim 2: Determine the effect of 5-HT1A-AR overexpression on 5-HT neurotransmission by in vivo microdialysis and electrophysiology. Aim 3: Determine the effect of 5-HT1A-AR overexpression in tests of neurovegetative function and depressive-like behavior. These studies should increase our understanding of the underlying causes of depression and other affective disorders, and may lead to new treatment strategies for patients suffering from these disorders.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
APOE4 dependent regulation of CSF Complement Pathway Activation in the development of Alzheimer's Disease
-
批准号:10650372
-
项目类别:
-
资助金额:$78.47万
-
财政年份:2022
-
负责人:Miles Berger
-
依托单位:
Low Neurophysiologic Resistance to Anesthetics as a Marker of Preclinical/Prodromal Alzheimer's Disease and Neurovascular Pathology, Delirium risk and Inattention
-
批准号:10870632
-
项目类别:
-
资助金额:$33.63万
-
财政年份:2022
-
负责人:Miles Berger
-
依托单位:
Low Neurophysiologic Resistance to Anesthetics as a Marker of Preclinical/Prodromal Alzheimer's Disease and Neurovascular Pathology, Delirium risk and Inattention
-
批准号:10671023
-
项目类别:
-
资助金额:$74.98万
-
财政年份:2022
-
负责人:Miles Berger
-
依托单位:
Low Neurophysiologic Resistance to Anesthetics as a Marker of Preclinical/Prodromal Alzheimer's Disease and Neurovascular Pathology, Delirium risk and Inattention
-
批准号:10521860
-
项目类别:
-
资助金额:$78.42万
-
财政年份:2022
-
负责人:Miles Berger
-
依托单位:
APOE4 dependent regulation of CSF Complement Pathway Activation in the development of Alzheimer's Disease
-
批准号:10871775
-
项目类别:
-
资助金额:$40.22万
-
财政年份:2022
-
负责人:Miles Berger
-
依托单位:
Neuro-inflammation in Postoperative Cognitive Dysfunction: CSF and fMRI Studies
-
批准号:9390592
-
项目类别:
-
资助金额:$24.3万
-
财政年份:2017
-
负责人:Miles Berger
-
依托单位:
Neuro-inflammation in Postoperative Cognitive Dysfunction: CSF and fMRI Studies
-
批准号:10598925
-
项目类别:
-
资助金额:$21.48万
-
财政年份:2017
-
负责人:Miles Berger
-
依托单位:
Neuro-inflammation in Postoperative Cognitive Dysfunction: CSF and fMRI Studies
-
批准号:9898206
-
项目类别:
-
资助金额:$23.68万
-
财政年份:2017
-
负责人:Miles Berger
-
依托单位:
Neuro-inflammation in Postoperative Cognitive Dysfunction: CSF and fMRI Studies
-
批准号:10160751
-
项目类别:
-
资助金额:$23.58万
-
财政年份:2017
-
负责人:Miles Berger
-
依托单位:
The Significance of Perioperative Changes in CSF tau levels in the Elderly
-
批准号:9123506
-
项目类别:
-
资助金额:$10.93万
-
财政年份:2015
-
负责人:Miles Berger
-
依托单位:
Role of 5-HT1A-AR overexpression in affective disorders
-
批准号:7281976
-
项目类别:
-
资助金额:$3.01万
-
财政年份:2005
-
负责人:Miles Berger
-
依托单位:
Role of 5-HT1A-AR overexpression in affective disorders
-
批准号:6994244
-
项目类别:
-
资助金额:$3.01万
-
财政年份:2005
-
负责人:Miles Berger
-
依托单位:
海外基金